Skip to main content
. 2020 Dec 20;12(12):3055. doi: 10.3390/polym12123055

Figure 3.

Figure 3

In vivo anti-tumor activity of G23-Dox/alg-Fe3O4 NPs. (A) Schematic representation of synthesis process and BBB penetrating Dox delivery. (B) In vivo MRI contrast imaging abilities of alg-Fe3O4 NPs and G23-alg-Fe3O4 NPs. (C) In vivo luminescence images show from U87MG-luc2 cells monitored using the IVIS imaging system after mice were intravenously injected with G23-Dox/alg-Fe3O4 NPs for seven days. (D) Body weights of mice during the treatment. Reproduced with permission from Reference [69].